These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11489965)

  • 1. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells.
    Rajagopalan S; Fu J; Long EO
    J Immunol; 2001 Aug; 167(4):1877-81. PubMed ID: 11489965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.
    Kikuchi-Maki A; Yusa S; Catina TL; Campbell KS
    J Immunol; 2003 Oct; 171(7):3415-25. PubMed ID: 14500636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma production and cytotoxicity of IL-2-activated murine NK cells are differentially regulated by MHC class I molecules.
    Kubota A; Lian RH; Lohwasser S; Salcedo M; Takei F
    J Immunol; 1999 Dec; 163(12):6488-93. PubMed ID: 10586040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways.
    Chuang SS; Kumaresan PR; Mathew PA
    J Immunol; 2001 Dec; 167(11):6210-6. PubMed ID: 11714782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.
    Hart OM; Athie-Morales V; O'Connor GM; Gardiner CM
    J Immunol; 2005 Aug; 175(3):1636-42. PubMed ID: 16034103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein.
    Kikuchi-Maki A; Catina TL; Campbell KS
    J Immunol; 2005 Apr; 174(7):3859-63. PubMed ID: 15778339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells.
    Ogasawara K; Yoshinaga SK; Lanier LL
    J Immunol; 2002 Oct; 169(7):3676-85. PubMed ID: 12244160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
    Faure M; Long EO
    J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIR2DL4 (CD158d) genotype influences expression and function in NK cells.
    Goodridge JP; Witt CS; Christiansen FT; Warren HS
    J Immunol; 2003 Aug; 171(4):1768-74. PubMed ID: 12902476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.
    Barakonyi A; Rabot M; Marie-Cardine A; Aguerre-Girr M; Polgar B; Schiavon V; Bensussan A; Le Bouteiller P
    J Immunol; 2004 Nov; 173(9):5349-54. PubMed ID: 15494480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21.
    Kalina U; Kauschat D; Koyama N; Nuernberger H; Ballas K; Koschmieder S; Bug G; Hofmann WK; Hoelzer D; Ottmann OG
    J Immunol; 2000 Aug; 165(3):1307-13. PubMed ID: 10903731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
    Vahlne G; Becker S; Brodin P; Johansson MH
    Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.
    Bryceson YT; March ME; Ljunggren HG; Long EO
    Blood; 2006 Jan; 107(1):159-66. PubMed ID: 16150947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors.
    Sabry M; Tsirogianni M; Bakhsh IA; North J; Sivakumaran J; Giannopoulos K; Anderson R; Mackinnon S; Lowdell MW
    J Immunol; 2011 Dec; 187(12):6227-34. PubMed ID: 22084431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking.
    Arase H; Arase N; Saito T
    J Exp Med; 1996 May; 183(5):2391-6. PubMed ID: 8642351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.